Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) ...

Cantor Fitzgerald reaffirmed their neutral rating on shares of Incyte (NASDAQ:INCY – Free Report) in a report released on Friday morning,Benzinga reports. INCY has been the subject of several other ...

Mustang Bio Inc (MBIO) stock saw a modest uptick, ending the day at $0.26 which represents a slight increase of $0.04 or 18.18% from the prior close of $0.22. The stock opened at $0.23 and touched a ...

Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...

We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...

Microvision Inc (MVIS) stock saw a modest uptick, ending the day at $1.27 which represents a slight increase of $0.08 or 6.72% from the prior close of $1.19. The stock opened at $1.17 and touched a ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...

In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Avita Medical (RCEL – Research Report), with a ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering ...